Compugen Ltd. Share Price
NASDAQ: CGENCompugen Ltd. Stock Performance
Compugen Ltd. Share Price Today
As of 29 October 2026, Compugen Ltd.'s share price is $2.03. The stock opened at $2.02, compared to its previous close of $2.00. During today's trading session, Compugen Ltd.'s share price traded between $2.00 and $2.04, with an average price of $2.02. Over the past 52 weeks, the stock has recorded a high of $3.23 and a low of $1.44. In terms of performance, Compugen Ltd.'s share price has declined by 23.68% over the last six months and is up 14.04% on a year-on-year basis.
Compugen Ltd. Share Price Chart
Compugen Ltd. Annual Profit & Loss
All figures in USD
About Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Compugen Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.44 | $2.03 | -15.10% |
Sep 2026 | $2.56 | $2.39 | -13.09% |
Aug 2026 | $2.30 | $2.75 | +16.53% |
Jul 2026 | $2.17 | $2.36 | +10.28% |
Jun 2026 | $2.54 | $2.14 | -18.94% |
May 2026 | $2.69 | $2.64 | -0.75% |
Apr 2026 | $2.19 | $2.66 | +25.47% |
Mar 2026 | $1.91 | $2.12 | +17.13% |
Feb 2026 | $1.85 | $1.81 | -1.63% |
Jan 2026 | $1.57 | $1.84 | +20.26% |
Dec 2025 | $1.56 | $1.53 | -1.92% |
Nov 2025 | $1.76 | $1.56 | -12.36% |